Drug companies led the Dow Jones higher on Monday, up 37.72 points (0.35%) to 10779.70, after US lawmakers gave the final approval to sweeping healthcare reforms on Sunday.
Although global drug makers will take a hit to earnings from 2011 when they will be forced to help pay for healthcare reform, they will benefit over the long term as an additional 32 million Americans become customers for their medicines. Shares in Pfizer Inc, the world's biggest drug maker and Merck & Co Inc both gained in early business, trading at $17.18, up 0.27 points (1.60%) and $38.86 0.80 points (2.10%) respectively. Elsewhere Boeing Co. continued its winning streak, after reporting mounting orders for its planes last week, rising 2.14% (1.52 points) to $72.37. However, com...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes